Search
Hot topics close

Remdesivir

gilead stock
47
  • Remdesivir Becomes First COVID-19 Treatment To Get FDA Approval
  • FDA's first COVID-19 treatment Gilead's remdesivir: 5 fast facts
  • Remdesivir Gets FDA Approval. What It Means for Gilead Stock and Vaccine Makers.
  • Gilead's stock rises as FDA formally approves remdesivir
  • Remdesivir becomes first Covid-19 treatment to receive FDA approval
  • FDA Approves First Treatment for COVID-19
  • COVID-19 drug remdesivir priced at $390 per vial for some patients, $520 for others
  • COVID-19 Drug Remdesivir Priced At More Than $3,100 Per Patient : Shots - Health News
  • Remdesivir, the First Coronavirus Drug, Gets a Price Tag
  • Gilead sets price of coronavirus drug remdesivir at $3,120 as Trump administration secures supply for 500,000 patients
  • Remdesivir for coronavirus: Gilead to charge thousands for treatment in U.S.
  • Here's how much Covid-19 drug remdesivir will cost
  • Coronavirus drug remdesivir to cost $3,120 per patient with private insurance
  • Gilead announces long-awaited price for Covid-19 drug remdesivir
  • Gilead’s remdesivir improves recovery time of coronavirus patients in NIH trial
  • Coronavirus Treatment: GILD Stock Pops On Positive Test Results
  • Remdesivir Speeds Recovery From COVID-19 In Preliminary Trial Results : Shots - Health News
  • Study: Remdesivir appears to speed recovery times in hospitalized COVID-19 patients
  • Remdesivir may change the fight against coronavirus
  • Remdesivir: Drug has 'clear cut' power to fight coronavirus